| Patent application number | Description | Published |
|---|
| 20090262716 | COMMUNICATION SYSTEM AND COMMUNICATION APPARATUS - A communication system includes: a service terminal configured to have a wireless LAN access point capability and a proximity communication capability, the wireless LAN access point capability enabling the service terminal to act as a wireless LAN access point to be connected via a network to a service provider providing a network connection service on a chargeable basis, the service terminal thereby offering the chargeable network connection service; and a user terminal configured to have a wireless LAN terminal capability and a proximity communication capability, the wireless LAN terminal capability enabling the user terminal to connect with the wireless LAN access point, the user terminal further connecting to the network using the chargeable network connection service. | 10-22-2009 |
| 20100223527 | DATA PROTECTION CIRCUIT, DATA PROTECTION METHOD, AND DATA PROCESSING APPARATUS - A generation unit in a data protection circuit acquires input data from one position on a path that outputs the input data as output data, and generates a second error detecting code. A check unit acquires the input data from another position on the path that is closer to an output side than the acquiring position in the generation unit, and checks the input data using a first error detecting code. Further, a connection unit connects the acquiring position in the generation unit and the acquiring position in the check unit so that the input data is acquired by the check unit subsequent to acquirement by the generation unit. | 09-02-2010 |
| 20100306837 | COMMUNICATION APPARATUS, MOBILE TERMINAL, COMMUNICATION SYSTEM, NON-CONTACT COMMUNICATION DEVICE, NETWORK CONNECTION METHOD, AND PROGRAM - A communication apparatus includes: a wireless communication unit connecting to a network via another apparatus by wireless communication; a settlement processing unit executing settlement processing of connection fees to the network by controlling a non-contact communication unit capable of reading out information stored in a non-contact communication device via non-contact communication, and writing information to the non-contact communication device via non-contact communication so as to update monetary information stored in the non-contact communication device; an authentication information recording unit controlling the non-contact communication unit to write authentication information, provided from the other apparatus when settlement processing by the settlement processing device is completed, to the non-contact communication device; and an authentication processing unit controlling the non-contact communication unit to read the authentication information from the non-contact communication device, and executing authentication processing as to the other apparatus using the authentication information, thereby establishing network connection by the wireless communication unit. | 12-02-2010 |
| Patent application number | Description | Published |
|---|
| 20090015292 | Semiconductor device having transfer gate between pre-buffer and main buffer - A semiconductor device includes a pre-buffer for transferring a data signal on the basis of a first power supply voltage, a main buffer for amplifying and outputting the data signal transferred by the pre-buffer on the basis of a second power supply voltage different from the first power supply voltage, a switch unit for controlling a conductive state between the pre-buffer and the main buffer on the basis of a switch control signal, and a control circuit for generating the switch control signal for controlling the pre-buffer to set an output level of the pre-buffer to ground potential in accordance with transition of logical level of the switch control signal. | 01-15-2009 |
| 20090237108 | Semiconductor integrated circuit - Provided is a semiconductor integrated circuit including: an output circuit connected between a power supply (VDD0) and a ground (GND0), having an input connected to an input terminal, and having an output connected to an output terminal; and a power-supply-noise cancelling circuit connected between the input terminal and the output terminal to generate a current that cancels a current flowing from the power supply (VDD0) to the output terminal or a current flowing from the output terminal to the ground (GND0), based on a potential difference between the input terminal and the output terminal. | 09-24-2009 |
| 20110025416 | Differential amplifier - A differential amplifier including: 1st transistor that is connected between 1st power-supply terminal and 1st output terminal, and has a control terminal receiving one of the differential input signals; 2nd transistor that is connected between 2nd power-supply terminal and 1st output terminal, and has a control terminal receiving the other of the differential input signals; 1st switch that is connected between 1st power-supply terminal and 1st transistor; 3rd transistor that is connected between 2nd power-supply terminal and 2nd output terminal, and has a control terminal is input to one of the differential input signals; 4th transistor that is connected between 1st power-supply terminal and 2nd output terminal, and has a control terminal receiving the other of the differential input signals; 2nd switch that is connected between 2nd power-supply terminal and 3rd transistor. Drive state of 1st and 2nd switches are controlled by a control signal. | 02-03-2011 |
| Patent application number | Description | Published |
|---|
| 20080274448 | Method for detecting a hydrophobic region of a target substance - An object of the present invention is to provides a method for detecting a hydrophobic region of a target substance that is capable of forming a hydrophobic region, such as a protein, which can detect a fluorescent analyte with high sensitivity with the use of a simple detection apparatus. The present invention provides a method for detecting a hydrophobic region of a target substance which comprises steps of allowing a target substance capable of forming a hydrophobic region to come into contact with a chemiluminescent substance, and assaying chemiluminescence. | 11-06-2008 |
| 20090036437 | PHARMACEUTICAL COMPOSITION COMPRISING PHENOXAZINIUM COMPOUND AS AN ACTIVE INGREDIENT - The purpose of the present invention is therefore to provide a pharmaceutical composition, especially that for the treatment and/or prevention of parasitic infection by protozoa, which has a high therapeutic effect and selective toxicity or a life-prolongation effect for the parasitic infection by protozoa. The present invention is therefore related to a pharmaceutical composition comprising the compound represented by the following general formula (1) as an active ingredient, especially to those for the treatment and/or prevention of parasitic infection by protozoa | 02-05-2009 |
| 20090311690 | VECTOR FOR SCREENING ANTIBODY - It is an object of the present invention to provide a simple and efficient means capable of evaluating the VH/VL interaction without expressing/purifying VH and VL. The present invention provides a recombinant vector comprising: (i) a nucleotide sequence which can express a hetero-assembly composed of two types of fusion proteins wherein heavy chain variable region (VH) and light chain variable region (VL) of antibody are respectively fused with mutually associable first polypeptide and second polypeptide, by means of secretion, or in a form of a fusion protein tethered to a phage coat protein; and (ii) a restriction enzyme recognition sequence at two sites within, or in a vicinity of, a nucleotide sequence encoding said first polypeptide or second polypeptide. | 12-17-2009 |
| 20100113789 | MEDICINAL COMPOSITION FOR PREVENTION OR TREATMENT OF PARASITIC PROTOZOAN INFECTION - The present invention is to provide a medicinal composition for preventing or treating parasitic protozoan infections, having a high selective toxicity against parasitic protozoan infection, and a superior preventive or treating effect. A medicinal composition for preventing or treating parasitic protozoan infections comprises a compound shown by the following general formula (1) as an active ingredient | 05-06-2010 |
| 20100210820 | PROTEIN REFOLDING COLUMN FILLER AND COLUMN - It is an object of the present invention to provide: a protein refolding column filler, which is effective for the refolding, namely, the activation of the function, of an inactive protein with an as yet unformed higher order structure produced in | 08-19-2010 |
| Patent application number | Description | Published |
|---|
| 20080254318 | Carbazole Derivative, and Light-Emitting Element and Light-Emitting Device Using the Carbzole Derivative - The present invention provides a material having excellent hole injecting and hole transporting properties. Moreover, the present invention provides a light-emitting element and a light-emitting device using the material having excellent hole injecting and hole transporting properties. The present invention provides a carbazole derivative represented by the general formula (1). By applying the carbazole derivative of the present invention to a light-emitting element or a light-emitting device, a lower driving voltage, enhanced emission efficiency, a longer lifetime and enhanced reliability of the light-emitting element or the light-emitting device can be realized. | 10-16-2008 |
| 20080284328 | Carbazole Derivative, and Light Emitting Element and Light Emitting Device Using the Carbazole Derivative - It is an object of the present invention to provide a material which is excellent in a hole injecting property and a hole transporting property, and to provide a light emitting element and a light emitting device using a material which is excellent in a hole injecting property and a hole transporting property. The present invention provides a carbazol derivative represented by a general formula (1). The carbazol derivative according to the present invention is excellent in the hole injecting property. By using the carbazol derivative according to the present invention as a hole injecting material for a hole injecting layer of a light emitting element, a driving voltage can be reduced. In addition, a lower driving voltage, improvement of the luminous efficiency, a longer life time, and higher reliability can be realized by applying the material to a light emitting element or a light emitting device. | 11-20-2008 |
| 20090015140 | Anthracene Derivative, Material for Light Emitting Element, Light Emitting Element, Light Emitting Device, and Electronic Device - It is an object of the present invention to provide a novel material capable of realizing excellent color purity of blue, and a light emitting element and a light emitting device using the novel material. Further, it is an object of the present invention to provide which is highly reliable, and a light emitting element and a light emitting device using the novel material. The structure for solving the above problems in accordance with the present invention is an anthracene derivative simultaneously having a diphenylanthracene structure and a carbazole skeleton in a molecule as represented by structural formula ( | 01-15-2009 |
| 20090058261 | CARBAZOLE DERIVATIVE, AND LIGHT EMITTING ELEMENT MATERIAL, LIGHT EMITTING ELEMENT, AND ELECTRONIC APPLIANCE OBTAINED USING THE SAME - An object is to provide a carbazole derivative that is useful as a raw material in manufacturing a light emitting element material having resistance to repetition of an oxidation reaction. The carbazole derivative is represented by General Formula (1) in the following. In General Formula (1), R | 03-05-2009 |
| 20090058267 | Light emitting element and light emitting device - One object of the present invention is to provide a light emitting element that includes an organic compound and an inorganic compound and has low driving voltage. The light emitting element of the invention includes a plurality of layers between a pair of electrodes, wherein the plurality of layers includes a layer that contains a carbazole derivative represented by a general formula (1) and an inorganic compound exhibiting an electron accepting property with respect to the carbazole derivative. By utilizing this structure, electrons are transported between the carbazole derivative and the inorganic compound and carriers are internally generated, and hence, the driving voltage of the light emitting element can be reduced. | 03-05-2009 |
| 20090102360 | ANTHRACENE DERIVATIVE, MATERIAL FOR LIGHT EMITTING ELEMENT, LIGHT EMITTING ELEMENT, LIGHT EMITTING DEVICE, AND ELECTRONIC APPLIANCE - The present invention provides an anthracene derivative represented by the following general formula (1). In the general formula (1), R1 and R2 individually represent hydrogen or an alkyl group having 1 to 4 carbon atoms, and at least one of R1 and R2 is hydrogen. Further, R3 represents an aryl group having 6 to 15 carbon atoms. R4 represents hydrogen, an alkyl group having 1 to 4 carbon atoms, or an aryl group having 6 to 15 carbon atoms. R5 represents hydrogen, an alkyl group having 1 to 4 carbon atoms, or an aryl group having 6 to 15 carbon atoms. R6 represents an aryl group having 6 to 15 carbon atoms. X1 represents an arylene group having 6 to 15 carbon atoms. General formula (1) is inserted. | 04-23-2009 |
| Patent application number | Description | Published |
|---|
| 20100033596 | SOLID-STATE IMAGE-CAPTURING APPARATUS, CAMERA, AND METHOD OF PROCESSING SIGNAL - A solid-state image-capturing apparatus that converts light, which is reflected from a subject, into an electrical signal, includes an image processing unit that performs edge enhancement on a digital video signal that is generated based on an analog video signal, which is obtained from the light captured by an image-capturing device and amplified with a predetermined analog gain, based on position information on the image-capturing device and the analog gain. | 02-11-2010 |
| 20100225781 | IMAGE PROCESSING DEVICE, IMAGE PROCESSING METHOD, AND IMAGING DEVICE - A pixel-interpolation processing unit generates a sensitivity level value of an insufficient color component according to interpolation processing of image signals. A sensitivity level value of an insufficient color component in a pixel of attention is calculated, according to an arithmetic operation corresponding to an acquired color component of the pixel of attention, by assuming a geometric figure including sensitivity level values of acquired color components as vertexes. As the geometric figure, the same figure is used irrespectively of which color component the acquired color component is. | 09-09-2010 |
| 20110069209 | IMAGE PROCESSING DEVICE AND SOLID- STATE IMAGING DEVICE - According to one embodiment, an image processing device includes a defect correcting unit, a noise-reduction processing unit, and a selecting unit. The defect correcting unit executes defect correction on a target pixel. The defect correcting unit switches, according to the level of contrast determined concerning a plurality of peripheral pixels, a first correction value obtained through averaging processing for signal values of the peripheral pixels and a second correction value other than the first correction value. | 03-24-2011 |
| 20110122273 | IMAGE PROCESSING APPARATUS AND CAMERA MODULE - According to the Embodiments, an Image Processing apparatus includes a pixel interpolation processing unit. The pixel interpolation processing unit generates a sensitivity level value through addition of a first frequency range component of an image signal for a lacking color component and a second frequency range component of a frequency band lower than the first frequency range component. The pixel interpolation processing unit adjusts a ratio of the first frequency range component to be added to the second frequency range component. | 05-26-2011 |
| Patent application number | Description | Published |
|---|
| 20080218134 | POWER SUPPLY APPARATUS - A power supply apparatus having a soft start function that enables a startup without any overshoot within an appropriate startup time regardless of whether the load is heavy or light. Even when output direct current voltage Vo has not yet risen upon startup, switch circuit | 09-11-2008 |
| 20090198841 | INTERFACE DETECTING CIRCUIT AND INTERFACE DETECTING METHOD - An interface detecting circuit and interface detecting method are provided, whereby operations can be carried out depending on peripheral devices connected to USB terminals, and whereby the system can be simplified and software load can be reduced. A pull-down resistor is connected to an ID terminal of a Mini-A receptacle of a peripheral device, the voltage generated by the pull-down resistor, which is pulled down by the ID terminal of the Mini-A receptacle of the peripheral device, and a pull-up resistor, which is pulled up by the ID terminal of a Mini-B receptacle of a device, is detected in an analog fashion, using a detecting section comprised of comparators, and, via a logic section, a logic output is subjected to noise cancellation in a filter section and is memorized in a register section. The operations of other devices are determined according to the states memorized in the register section. | 08-06-2009 |
| Patent application number | Description | Published |
|---|
| 20080233637 | MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS - The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MRT-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma. | 09-25-2008 |
| 20080286804 | MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS - The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma. | 11-20-2008 |
| 20080289055 | MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS - The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma. | 11-20-2008 |
| 20080292647 | MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS - The present invention provides a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1. This invention further relates to bioassays using the nucleic acid sequence, protein or antibodies of this invention to diagnose, assess or prognoses a mammal afflicted with melanoma or metastata melanoma. This invention also provides immunogenic peptides derived from the MART-1 melanoma antigen and a second melanoma antigen designated gp100. This invention further provides immunogenic peptides derived from the MART-1 melanoma antigen or gp100 antigen which have been modified to enhance their immunogenicity. The proteins and peptides provided can serve as an immunogen or vaccine to prevent or treat melanoma. | 11-27-2008 |
| 20110027299 | MELANOMA ANTIGENS AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC METHODS - The present invention provides an isolated or purified immunogenic peptide comprising 8-15 contiguous amino acids of gp100 (SEQ ID NO: 121) and related nucleic acids, expression vectors, host cells, populations of cells, and methods of use. The invention further provides immunogenic peptides derived from gp100 which have been modified to enhance their immunogenicity and related nucleic acids, expression vectors, host cells, populations of cells, and methods of use. | 02-03-2011 |
